Income Statement Medical Net, Inc.

Stocks

3645

JP3752400006

Healthcare Facilities & Services

Market Closed - Japan Exchange 02:24:47 2026-08-20 EDT			5-day change	1st Jan Change
243.00 ^JPY	0.00%		-0.41%	-18.46%

05-31	Tokyo Stock Exchange Issues Supervisory Designations for Three Firms Over Delisting Concerns	MT
25-07-17	Medical Net, Inc. announced that it has received ¥155.1168 million in funding from Yoshida Co.,Ltd.	CI

01bd8e7c16b65b770.EEfocylxG-l9lJEZZ7LmPxmS0d0Ch6Xpv6Vy0MwQq8Q.Ih-PXk4iL4IK-996N-eSCiv-l6hD2PLc4MwWuLhbkoZcIoNBeAZJpCyjxA

Published financial data: MEDICAL NET, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: May	2021	2022	2023	2024	2025
Revenues	3.33B	3.74B	4.5B	5.25B	6.08B
Total Revenues	3.33B	3.74B	4.5B	5.25B	6.08B
Cost of Goods Sold, Total	2.15B	2.28B	2.72B	3.41B	4.11B
Gross Profit	1.18B	1.46B	1.78B	1.84B	1.96B
Selling General & Admin Expenses, Total	845M	1B	1.4B	1.52B	1.86B
Provision for Bad Debts	1M	10M	5M	18M	2M
Other Operating Expenses, Total	846M	1.01B	1.4B	1.54B	1.87B
Operating Income	331M	450M	379M	299M	99M
Interest Expense, Total	-1M	-1M	-3M	-6M	-11M
Interest And Investment Income	-	-	-	1M	3M
Net Interest Expenses	-1M	-1M	-3M	-5M	-8M
Currency Exchange Gains (Loss)	2M	8M	45M	34M	25M
Other Non Operating Income (Expenses)	3M	-5M	10M	-7M	18M
EBT, Excl. Unusual Items	335M	452M	431M	321M	134M
Gain (Loss) On Sale Of Investments	-81M	84M	-40M	-4M	352M
Gain (Loss) On Sale Of Assets	-	-	2M	5M	-
Asset Writedown	-	-	-143M	-170M	-154M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-1M	-	-	-1M	-308M
EBT, Incl. Unusual Items	253M	536M	250M	151M	24M
Income Tax Expense	116M	137M	141M	126M	62M
Earnings From Continuing Operations	137M	399M	109M	25M	-38M
Net Income to Company	137M	399M	109M	25M	-38M
Minority Interest	-8M	-15M	7M	-20M	-30M
Net Income - (IS)	129M	384M	116M	5M	-68M
Net Income to Common Incl Extra Items	129M	384M	116M	5M	-68M
Net Income to Common Excl. Extra Items	129M	384M	116M	5M	-68M
Per Share Items
Net EPS - Basic	15.28	43.88	12.95	0.55	-7.62
Basic EPS - Continuing Operations	15.28	43.88	12.95	0.55	-7.62
Basic Weighted Average Shares Outstanding	8.44M	8.75M	8.96M	9.05M	8.92M
Net EPS - Diluted	15.28	43.88	12.95	0.55	-7.62
Diluted EPS - Continuing Operations	15.28	43.88	12.95	0.55	-7.62
Diluted Weighted Average Shares Outstanding	8.44M	8.75M	8.96M	9.05M	8.92M
Normalized Basic EPS	23.85	30.57	30.84	19.97	6.02
Normalized Diluted EPS	23.85	30.57	30.84	19.97	6.02
Dividend Per Share	2.5	2.5	2.5	3	3
Payout Ratio	4.65	8.85	30.17	440	-38.24
Supplemental Items
EBITDA	355M	479M	440M	352M	175M
EBITA	344M	465M	425M	333M	144M
EBIT	331M	450M	379M	299M	99M
Effective Tax Rate - (Ratio)	45.85	25.56	56.4	83.44	258.33
Normalized Net Income	201M	268M	276M	181M	53.75M
Non-Cash Pension Expense	-	-	5.28M	-4.1M	-1.81M
Supplemental Operating Expense Items
Advertising Expense	72M	108M	119M	119M	154M
Selling and Marketing Expenses	72M	108M	119M	119M	154M
General and Administrative Expenses	118M	149M	157M	173M	182M
Research And Development Expense From Footnotes	11M	8M	-	7M	23M

Fiscal Period: May	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	868M	1.13B	1.52B	1.53B	1.46B
Total Cash And Short Term Investments	868M	1.13B	1.52B	1.53B	1.46B
Accounts Receivable, Total	444M	649M	674M	834M	884M
Total Receivables	444M	649M	674M	834M	884M
Inventory	29M	129M	123M	206M	318M
Other Current Assets, Total	164M	166M	144M	266M	300M
Total Current Assets	1.5B	2.08B	2.46B	2.83B	2.96B
Net Property Plant And Equipment	39M	106M	111M	125M	133M
Long-term Investments	279M	411M	497M	469M	195M
Goodwill	188M	462M	293M	446M	394M
Other Intangibles, Total	16M	15M	12M	14M	34M
Loans Receivable Long-Term	51M	47M	44M	41M	291M
Deferred Tax Assets Long-Term	28M	34M	49M	58M	75M
Other Long-Term Assets, Total	1M	2M	2M	2M	-
Total Assets	2.11B	3.15B	3.47B	3.99B	4.08B
Liabilities
Accounts Payable, Total	111M	259M	322M	436M	408M
Accrued Expenses, Total	-	-	-	-	21M
Short-term Borrowings	240M	630M	680M	530M	846M
Current Portion of Long-Term Debt	18M	32M	27M	112M	69M
Current Income Taxes Payable	106M	91M	90M	69M	17M
Other Current Liabilities	247M	288M	318M	475M	570M
Total Current Liabilities	722M	1.3B	1.44B	1.62B	1.93B
Long-Term Debt	124M	111M	82M	387M	336M
Pension & Other Post Retirement Benefits	-	5M	11M	40M	40M
Other Non Current Liabilities	2M	2M	9M	10M	6M
Total Liabilities	848M	1.42B	1.54B	2.06B	2.31B
Common Stock, Total	286M	286M	286M	286M	286M
Additional Paid In Capital	233M	287M	337M	337M	337M
Retained Earnings	1.28B	1.63B	1.71B	1.69B	1.6B
Treasury Stock	-563M	-511M	-443M	-443M	-543M
Comprehensive Income and Other	3M	11M	26M	33M	37M
Total Common Equity	1.24B	1.71B	1.92B	1.91B	1.72B
Minority Interest	17M	29M	12M	24M	52M
Total Equity	1.26B	1.74B	1.93B	1.93B	1.77B
Total Liabilities And Equity	2.11B	3.15B	3.47B	3.99B	4.08B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.62M	8.82M	9.05M	9.05M	9.27M
ECS Total Common Shares Outstanding	8.62M	8.82M	9.05M	9.05M	8.73M
Book Value / Share	144.12	193.63	211.82	210.72	196.41
Tangible Book Value	1.04B	1.23B	1.61B	1.45B	1.29B
Tangible Book Value Per Share	120.45	139.52	178.1	159.86	147.39
Total Debt	382M	773M	789M	1.03B	1.25B
Net Debt	-486M	-360M	-729M	-499M	-205M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	5.1M	11.06M	40.86M	40.27M
Minority Interest, Total (Incl. Fin. Div)	17M	29M	12M	24M	52M
Inventories - Finished Goods, Total	29M	129M	123M	206M	318M
Full Time Employees	113	163	186	274	296
Accumulated Allowance for Doubtful Accounts (Supple)	21M	15M	19M	8M	60M

Fiscal Period: May	2021	2022	2023	2024	2025
Net Income	254M	538M	250M	153M	25M
Depreciation & Amortization - CF	11M	14M	15M	19M	31M
Amortization of Goodwill and Intangible Assets - (CF)	13M	15M	46M	34M	45M
Depreciation & Amortization, Total	24M	29M	61M	53M	76M
(Gain) Loss From Sale Of Asset	-	-	141M	165M	154M
(Gain) Loss on Sale of Investments - (CF)	81M	-	40M	4M	-352M
Other Operating Activities, Total	-20M	-159M	-158M	-159M	-122M
Change In Accounts Receivable	-27M	-44M	-30M	-115M	-62M
Change In Inventories	-1M	-28M	5M	-72M	-95M
Change In Accounts Payable	61M	24M	62M	45M	-98M
Change in Other Net Operating Assets	19M	-18M	58M	45M	394M
Cash from Operations	391M	342M	429M	119M	-80M
Capital Expenditure	-13M	-2M	-19M	-32M	-131M
Sale of Property, Plant, and Equipment	-	-	4M	5M	-
Cash Acquisitions	-48M	-340M	-	-224M	-33M
Divestitures	-	-	-	-	-52M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-21M	-3M	-27M	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	5M	3M	3M	3M	-7M
Other Investing Activities, Total	-10M	-13M	-23M	-37M	-36M
Cash from Investing	-87M	-355M	-62M	-285M	-259M
Short Term Debt Issued, Total	-	390M	50M	-	299M
Long-Term Debt Issued, Total	100M	-	-	360M	130M
Total Debt Issued	100M	390M	50M	360M	429M
Short Term Debt Repaid, Total	-110M	-	-	-150M	-
Long-Term Debt Repaid, Total	-18M	-74M	-33M	-37M	-79M
Total Debt Repaid	-128M	-74M	-33M	-187M	-79M
Repurchase of Common Stock	-	-	-	-	-99M
Common Dividends Paid	-6M	-34M	-35M	-22M	-26M
Common & Preferred Stock Dividends Paid	-6M	-34M	-35M	-22M	-26M
Other Financing Activities, Total	-	-	1M	-7M	-6M
Cash from Financing	-34M	282M	-17M	144M	219M
Foreign Exchange Rate Adjustments	2M	-9M	35M	16M	17M
Miscellaneous Cash Flow Adjustments	-	-	-1M	1M	-1M
Net Change in Cash	272M	260M	384M	-5M	-104M
Supplemental Items
Cash Interest Paid	1M	1M	3M	6M	11M
Cash Income Tax Paid (Refund)	26M	160M	159M	158M	123M
Levered Free Cash Flow	329M	175M	372M	89.12M	-160M
Unlevered Free Cash Flow	330M	175M	374M	92.88M	-153M
Change In Net Working Capital	-112M	133M	-95M	115M	160M
Net Debt Issued / Repaid	-28M	316M	17M	173M	350M

Fiscal Period: May	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.77	10.69	7.16	5.01	1.53
Return on Total Capital	13.54	13.55	9.07	6.58	2.07
Return On Equity %	12.1	26.64	5.95	1.3	-2.06
Return on Common Equity	11.53	26.04	6.4	0.26	-3.76
Margin Analysis
Gross Profit Margin %	35.35	38.99	39.56	35.05	32.34
SG&A Margin	25.38	26.7	31.02	29.02	30.67
EBITDA Margin %	10.66	12.79	9.78	6.7	2.88
EBITA Margin %	10.33	12.42	9.44	6.34	2.37
EBIT Margin %	9.94	12.02	8.42	5.69	1.63
Income From Continuing Operations Margin %	4.11	10.65	2.42	0.48	-0.63
Net Income Margin %	3.87	10.25	2.58	0.1	-1.12
Net Avail. For Common Margin %	3.87	10.25	2.58	0.1	-1.12
Normalized Net Income Margin	6.05	7.14	6.14	3.44	0.88
Levered Free Cash Flow Margin	9.89	4.66	8.27	1.7	-2.63
Unlevered Free Cash Flow Margin	9.91	4.68	8.31	1.77	-2.52
Asset Turnover
Asset Turnover	1.73	1.42	1.36	1.41	1.51
Fixed Assets Turnover	86.49	51.66	41.47	44.51	47.11
Receivables Turnover (Average Receivables)	7.74	6.85	6.8	6.97	7.07
Inventory Turnover (Average Inventory)	75.54	28.92	21.59	20.74	15.69
Short Term Liquidity
Current Ratio	2.08	1.6	1.71	1.75	1.53
Quick Ratio	1.82	1.37	1.53	1.46	1.21
Operating Cash Flow to Current Liabilities	0.54	0.26	0.3	0.07	-0.04
Days Sales Outstanding (Average Receivables)	47.19	53.26	53.66	52.54	51.59
Days Outstanding Inventory (Average Inventory)	4.83	12.62	16.91	17.65	23.26
Average Days Payable Outstanding	18.22	28.31	39.07	39.7	36.47
Cash Conversion Cycle (Average Days)	33.8	37.57	31.49	30.49	38.38
Long Term Solvency
Total Debt/Equity	30.34	44.53	40.92	53.32	70.8
Total Debt / Total Capital	23.28	30.81	29.04	34.78	41.45
LT Debt/Equity	9.85	6.39	4.25	20.05	19.02
Long-Term Debt / Total Capital	7.56	4.42	3.02	13.08	11.13
Total Liabilities / Total Assets	40.25	44.96	44.39	51.62	56.69
EBIT / Interest Expense	331	450	126.33	49.83	9
EBITDA / Interest Expense	355	479	146.67	58.67	15.91
(EBITDA - Capex) / Interest Expense	342	477	140.33	53.33	4
Total Debt / EBITDA	1.08	1.61	1.79	2.92	7.15
Net Debt / EBITDA	-1.37	-0.75	-1.66	-1.42	-1.17
Total Debt / (EBITDA - Capex)	1.12	1.62	1.87	3.22	28.43
Net Debt / (EBITDA - Capex)	-1.42	-0.75	-1.73	-1.56	-4.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.16	12.46	20.16	16.71	15.71
Gross Profit, 1 Yr. Growth %	21.09	24.04	21.92	3.43	6.74
EBITDA, 1 Yr. Growth %	184	34.93	-8.14	-20	-50.28
EBITA, 1 Yr. Growth %	196.55	35.17	-8.6	-21.65	-56.76
EBIT, 1 Yr. Growth %	212.26	35.95	-15.78	-21.11	-66.89
Earnings From Cont. Operations, 1 Yr. Growth %	65.06	191.24	-72.68	-77.06	-252
Net Income, 1 Yr. Growth %	63.29	197.67	-69.79	-95.69	-1.46K
Normalized Net Income, 1 Yr. Growth %	233.54	32.84	3.32	-34.64	-70.24
Diluted EPS Before Extra, 1 Yr. Growth %	65.83	187.19	-70.5	-95.73	-1.48K
Accounts Receivable, 1 Yr. Growth %	6.47	46.17	3.85	23.74	6
Inventory, 1 Yr. Growth %	3.57	344.83	-4.65	67.48	54.37
Net Property, Plant and Equip., 1 Yr. Growth %	2.63	171.79	4.72	12.61	6.4
Total Assets, 1 Yr. Growth %	21.37	49.69	9.92	15.06	2.28
Tangible Book Value, 1 Yr. Growth %	25.21	18.5	30.98	-10.24	-11
Common Equity, 1 Yr. Growth %	24.7	37.44	12.24	-0.52	-10.02
Cash From Operations, 1 Yr. Growth %	401.28	-12.53	25.44	-72.26	-167.23
Capital Expenditures, 1 Yr. Growth %	62.5	-84.62	850	68.42	309.38
Levered Free Cash Flow, 1 Yr. Growth %	1.08K	-46.96	113.03	-76.04	-279.52
Unlevered Free Cash Flow, 1 Yr. Growth %	1.03K	-46.87	113.34	-75.16	-264.87
Dividend Per Share, 1 Yr. Growth %	233.33	0	0	20	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22.04	13.31	16.25	18.42	16.21
Gross Profit, 2 Yr. CAGR %	15.58	22.56	22.98	12.29	5.07
EBITDA, 2 Yr. CAGR %	35.27	95.75	11.33	-14.28	-36.93
EBITA, 2 Yr. CAGR %	36.73	100.22	11.15	-15.38	-41.79
EBIT, 2 Yr. CAGR %	37.14	106.04	7.01	-18.49	-48.89
Earnings From Cont. Operations, 2 Yr. CAGR %	15.89	119.25	-10.8	-74.97	-40.96
Net Income, 2 Yr. CAGR %	12.46	120.47	-5.17	-88.59	-23.44
Normalized Net Income, 2 Yr. CAGR %	33.05	110.49	17.15	-17.83	-55.9
Diluted EPS Before Extra, 2 Yr. CAGR %	27.03	118.23	-7.96	-88.78	-23.28
Accounts Receivable, 2 Yr. CAGR %	2.45	24.75	23.21	13.36	14.52
Inventory, 2 Yr. CAGR %	14.81	114.64	105.95	26.37	60.79
Net Property, Plant and Equip., 2 Yr. CAGR %	2.67	67.02	68.71	8.59	9.46
Total Assets, 2 Yr. CAGR %	1.36	34.79	28.28	12.46	8.48
Tangible Book Value, 2 Yr. CAGR %	-15.71	21.81	24.58	8.43	-10.62
Common Equity, 2 Yr. CAGR %	-12.82	30.91	24.2	5.67	-5.39
Cash From Operations, 2 Yr. CAGR %	321.58	109.39	4.75	-41.01	-56.82
Capital Expenditures, 2 Yr. CAGR %	-17.28	-50	20.89	300	162.58
Levered Free Cash Flow, 2 Yr. CAGR %	94.54	149.73	6.29	-28.56	-34.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	94.72	144.77	6.46	-27.2	-36
Dividend Per Share, 2 Yr. CAGR %	58.11	82.57	0	9.54	9.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	24.16	18.76	15.55	16.4	17.51
Gross Profit, 3 Yr. CAGR %	9.85	18.34	22.34	16.08	10.41
EBITDA, 3 Yr. CAGR %	28.58	35.16	52.12	-0.28	-28.51
EBITA, 3 Yr. CAGR %	29.88	36.21	54.16	-1.08	-32.34
EBIT, 3 Yr. CAGR %	29.33	36.74	52.91	-3.33	-39.63
Earnings From Cont. Operations, 3 Yr. CAGR %	22.24	57.56	9.51	-43.28	-54.33
Net Income, 3 Yr. CAGR %	13.6	55.56	13.66	-66.16	-43.84
Normalized Net Income, 3 Yr. CAGR %	22.61	32.98	66.04	-3.56	-41.43
Diluted EPS Before Extra, 3 Yr. CAGR %	23.21	66.73	12	-66.93	-44.21
Accounts Receivable, 3 Yr. CAGR %	16.75	15.34	17.36	23.38	10.85
Inventory, 3 Yr. CAGR %	-	80.32	63.78	92.23	35.09
Net Property, Plant and Equip., 3 Yr. CAGR %	3.67	42.03	42.95	47.44	7.86
Total Assets, 3 Yr. CAGR %	3.8	15.42	25.93	23.71	8.96
Tangible Book Value, 3 Yr. CAGR %	-11.17	-5.58	24.79	11.68	1.52
Common Equity, 3 Yr. CAGR %	-7.02	1.47	24.37	15.35	0.16
Cash From Operations, 3 Yr. CAGR %	49.94	149.58	76.52	-32.73	-38.38
Capital Expenditures, 3 Yr. CAGR %	37.51	-52.78	33.42	35.02	303.1
Levered Free Cash Flow, 3 Yr. CAGR %	37.15	26.14	136.84	-35.31	-2.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.24	26.29	133.81	-34.46	-4.4
Dividend Per Share, 3 Yr. CAGR %	35.72	35.72	49.38	6.27	6.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.58	20.4	20.93	18.62	15.81
Gross Profit, 5 Yr. CAGR %	11.7	14.04	14.92	15.88	15.12
EBITDA, 5 Yr. CAGR %	12.73	28.83	21.38	12.65	6.96
EBITA, 5 Yr. CAGR %	13.45	29.84	22.04	12.6	4.42
EBIT, 5 Yr. CAGR %	13.47	29.62	19.89	11.18	-1.36
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.33	37.56	7.76	-24.51	-14.47
Net Income, 5 Yr. CAGR %	-7.06	36.18	5.68	-45.29	-2.95
Normalized Net Income, 5 Yr. CAGR %	13.69	27.59	20.4	9.69	-2.3
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.38	41.96	9.65	-43.34	-3.73
Accounts Receivable, 5 Yr. CAGR %	20.74	25.08	19.29	14.54	16.22
Inventory, 5 Yr. CAGR %	-	-	-	56.42	62.58
Net Property, Plant and Equip., 5 Yr. CAGR %	22.74	57.32	25.97	27.57	28.47
Total Assets, 5 Yr. CAGR %	4.78	12.24	12.97	14.23	18.64
Tangible Book Value, 5 Yr. CAGR %	-5.25	-3.02	1.7	-0.21	9.2
Common Equity, 5 Yr. CAGR %	-2.75	2.7	4.4	3.13	11.48
Cash From Operations, 5 Yr. CAGR %	4.68	36.19	29.9	40.16	0.51
Capital Expenditures, 5 Yr. CAGR %	26.58	-	30.6	10.99	74.92
Levered Free Cash Flow, 5 Yr. CAGR %	33.72	20.8	23.86	0.48	41.71
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.77	20.89	23.98	1.32	39.25
Dividend Per Share, 5 Yr. CAGR %	20.11	20.11	20.11	24.57	31.95